OLD PHARMA at CPHI Worldwide 2026: Meet Us in Milan
Milan, 6-8 October 2026. We are pleased to announce that OLD PHARMA will be attending CPHI Worldwide 2026, taking place in Milan, Italy, from October 6–8, 2026. As one of…
Raw materials and tensions in the Middle East: OLD PHARMA’s strategies for safeguarding pharmaceutical supplies
How is a pharmaceutical supply chain protected? Inside OLD PHARMA's new Risk Assessment. Recent geopolitical tensions in the Middle East, culminating in the involvement of Iran, are completely reshaping global…
Cefuroxime, how to combine maximum stability and innovative formulation?
In the dynamic sector of mature antibiotics, second-generation cephalosporins continue to play an irreplaceable role for global public health. Among these, cefuroxime stands out as one of the most versatile…
OLD PHARMA at CPHI & PMEC China 2026: focus on innovation and international relations
OLD PHARMA confirms its commitment to developing a global network by participating in CPHI & PMEC China 2026, scheduled to take place in Shanghai from 16 to 18 June 2026,…
OLD PHARMA at the 65th AFI Symposium 2026: New Solutions for the Pharmaceutical Industry
OLD PHARMA will participate in the 65th AFI Symposium, scheduled for June 10-12, 2026, in Rimini, Italy. This is a key event for the Italian and international pharmaceutical industry. The…
Old Pharma International, a Prodotti Gianni group company, acquires Actim S.r.l.
A strategic transaction strengthening its position across the pharmaceutical and chemical pharmaceutical supply chain OLD PHARMA International S.r.l., a company of the Prodotti Gianni S.r.l. Group, announces the acquisition of…
Ceftazidime: Why This Cephalosporin Remains Vital for Global Health Security
We have already discussed in our previous article the importance of Ceftriaxone and its role as a therapeutic standard. Ceftazidime, which we will address today, should instead be regarded as…
Ceftriaxone: Why One of the World’s Most Widely Used Antibiotics Is at Risk of Becoming Hard to Find
The relevance of ceftriaxone in 2026 has not diminished—quite the opposite. Current challenges linked to antimicrobial resistance and the increasing volatility of global supply chains have further amplified its strategic…
Why Are We Still Talking About Cephalosporins in 2026?
The active role and clinical value of cephalosporins in modern antibiotic therapy, with a focus on supply chain dynamics and future scenarios. What Are Third Generation Cephalosporins? Cephalosporins belong to…
Clindamycin: A Classic Antibiotic That Continues to Deliver Therapeutic and Industrial Value
For those involved in the distribution and supply of APIs (Active Pharmaceutical Ingredients), clindamycin is a concrete example of how a well-established drug can continue to generate high-level industrial and…
A Christmas of shared commitment: OLD PHARMA supporting the association Uno in Più
This Christmas, OLD PHARMA has chosen to support a project that reflects the values it fully embraces: inclusion, respect for the individual and responsibility toward the community. The contribution is…
GDP Certification. An official recognition of OLD PHARMA’s consolidated practices in pharmaceutical distribution
OLD PHARMA is pleased to announce the achievement of the GDP Good Distribution Practices certification, a result that confirms full compliance with international standards for the distribution of pharmaceutical active…
Aflibercept: the innovation that has revolutionized retinal disease therapy
In recent years, the treatment of retinal diseases has experienced remarkable progress. Conditions that once led to inevitable visual deterioration can now be effectively and durably controlled. Among the key…
Lactulose: a cornerstone therapy with growing market perspectives
A well-established therapeutic profile Lactulose is a synthetic disaccharide derived from lactose and has been widely used in clinical practice for decades. Recognized for its safety and efficacy, it is…
Artificial Intelligence in the Pharmaceutical Industry: Unlocking Present Value and Shaping the Future
The pharmaceutical industry is undergoing a radical transformation, and at the heart of this evolution lies Artificial Intelligence (AI) and Generative AI (GenAI). Once considered futuristic, these technologies are now…
CPHI 2024 Milan: A Success for OLD PHARMA and Prodotti Gianni, Moving Towards New Business Opportunities
The CPHI 2024 has now concluded, and we at OLD PHARMA have returned from CPHI Milan 2024 with an extremely positive experience and full of new stimuli. The event, one…
Amikacin: Mechanism of Action and Antibiotic-Resistance Evaluations.
Amikacin is an antibiotic belonging to the aminoglycoside group, known for its efficacy in treating serious infections caused by Gram-negative bacteria. This drug is used in settings where pathogens are…
OLD PHARMA earns the “Committed” badge from EcoVadis: A significant milestone in our ESG journey
We are proud to announce that OLD PHARMA has reached an important milestone in its sustainability journey by earning the prestigious “Committed” badge from EcoVadis, one of the world’s leading…
CPHI Milano 8-10 October 2024 – Old Pharma and Prodotti Gianni: a strategic collaboration for the success of your business
2 Companies, 1 Mission. Old Pharma and Prodotti Gianni together for the first time at CPHI Milano 2024, the international reference event for the pharmaceutical sector that will be held…
The Eye Health: Proper Management of Inflammation
Eye health is a vital aspect of overall well-being that is often overlooked until visible or painful problems arise. Of the many conditions that can affect the eye, inflammation is…